QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
NASDAQ:ALNA

Allena Pharmaceuticals News Headlines

$0.12
+0.01 (+8.77%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.11
$0.13
50-Day Range
$0.08
$0.48
52-Week Range
$0.07
$1.45
Volume
11.74 million shs
Average Volume
6.40 million shs
Market Capitalization
$11.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.97
Get Allena Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Allena Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALNA
News Sentiment

0.84

0.29

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALNA Articles
This Week

3

0

ALNA Articles
Average Week



Allena Pharmaceuticals (NASDAQ:ALNA) News Headlines Today

SourceHeadline
msn.com logoShort Volatility Alert: Allena Pharmaceuticals
msn.com - May 16 at 3:36 PM
MarketBeat logoShort Interest in Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Decreases By 35.8%
americanbankingnews.com - May 15 at 2:44 AM
investorplace.com logoALNA Stock Alert: 5 Things to Know as Little-Known Allena Pharmaceuticals Soars 100%
investorplace.com - May 12 at 11:01 AM
seekingalpha.com logoNano cap stock Allena surges on heavy volume
seekingalpha.com - May 12 at 9:56 AM
seekingalpha.com logoAllena Pharmaceuticals $2.8M direct offering
seekingalpha.com - May 4 at 10:57 AM
finance.yahoo.com logoAllena Pharmaceuticals Announces $2.8 Million Registered Direct Offering
finance.yahoo.com - May 4 at 10:57 AM
MarketBeat logoAllena Pharmaceuticals, Inc. (NASDAQ:ALNA) Sees Significant Decrease in Short Interest
americanbankingnews.com - May 3 at 2:40 AM
seekingalpha.com logoAllena downgraded to Neutral at B. Riley citing the end to lead clinical program
seekingalpha.com - March 22 at 6:11 PM
finance.yahoo.com logoWhy Are Allena Pharma Shares Plunging Today
finance.yahoo.com - March 21 at 6:06 PM
seekingalpha.com logoAllena extends losses on plans to end trial for lead asset and financial concerns
seekingalpha.com - March 21 at 8:48 AM
finance.yahoo.com logoAllena Pharmaceuticals, Inc. (ALNA)
finance.yahoo.com - March 1 at 10:14 PM
fool.com logoAllena Pharmaceuticals, Inc.(ALNA)
fool.com - January 29 at 6:02 PM
finance.yahoo.com logoAllena Stock Is Surging In Premarket Today As It Explores Strategic, Financing Alternatives
finance.yahoo.com - January 4 at 12:28 PM
finance.yahoo.com logoAllena Pharmaceuticals Provides Clinical and Corporate Update
finance.yahoo.com - January 4 at 7:28 AM
finance.yahoo.com logoAllena Pharmaceuticals (ALNA) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - November 22 at 1:08 PM
finance.yahoo.com logoAfter Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)
finance.yahoo.com - November 22 at 1:08 PM
finance.yahoo.com logoAllena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - November 22 at 1:08 PM
finance.yahoo.com logoAllena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare Conference
finance.yahoo.com - November 15 at 5:59 PM
finance.yahoo.com logoAllena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporate Progress
finance.yahoo.com - November 10 at 7:23 PM
marketwatch.com logoAllena Pharmaceuticals Gets Fast Track Designation for Kidney Disease Treatment
marketwatch.com - November 3 at 9:21 AM
finance.yahoo.com logoAllena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
finance.yahoo.com - November 3 at 9:21 AM
finance.yahoo.com logoAllena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346
finance.yahoo.com - September 29 at 6:40 PM
finance.yahoo.com logoAllena Pharmaceuticals to Participate in H.C. Wainwright’s 23rd Annual Global Investment Conference
finance.yahoo.com - September 9 at 6:27 PM
finance.yahoo.com logoAllena Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Corporate Progress
finance.yahoo.com - August 10 at 5:41 PM
finance.yahoo.com logoAllena Pharma Stock Under Pressure After Equity Raise Of $28M
finance.yahoo.com - July 14 at 12:05 PM
finance.yahoo.com logoAllena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - July 14 at 2:05 AM
benzinga.com logoAllena Revises Interim Reloxaliase Analysis Targeted Now For Q1 2022; ALLN-346 Phase 2 Data On Track For End Of 2021
benzinga.com - July 12 at 1:16 PM
finance.yahoo.com logoAllena Pharmaceuticals Provides Update on Clinical Development Programs
finance.yahoo.com - July 12 at 8:15 AM
finance.yahoo.com logoAllena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference
finance.yahoo.com - July 8 at 8:42 PM
finance.yahoo.com logoAllena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chronic Kidney Disease
finance.yahoo.com - June 8 at 1:04 PM
finance.yahoo.com logoMoving Average Crossover Alert: Allena Pharmaceuticals (ALNA)
finance.yahoo.com - May 12 at 7:14 AM
finance.yahoo.com logoAllena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 11 at 12:42 PM
finance.yahoo.com logoAllena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - April 8 at 9:45 AM
nasdaq.com logoHow Many Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) Shares Have Insiders Sold, In The Last Year?
nasdaq.com - April 7 at 6:10 PM
finance.yahoo.com logoAllena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors
finance.yahoo.com - April 7 at 8:09 AM
finance.yahoo.com logoAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 9 at 8:24 AM
marketwatch.com logoTop Penny Stocks On Robinhood If Biotech Is Your Focus Right Now
marketwatch.com - February 24 at 10:48 PM
finance.yahoo.com logoAllena Pharmaceuticals to Present at Upcoming Investor Conferences in March
finance.yahoo.com - February 24 at 12:46 PM
finance.yahoo.com logoAre Institutions Heavily Invested In Allena Pharmaceuticals, Inc.'s (NASDAQ:ALNA) Shares?
finance.yahoo.com - February 5 at 7:51 AM
finance.yahoo.com logoAllena Pharmaceuticals Appoints Richard D. Katz, M.D. as Chief Financial Officer
finance.yahoo.com - February 2 at 11:59 AM
finance.yahoo.com logoHas Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - January 12 at 5:27 PM
finance.yahoo.com logoAllena Pharmaceuticals, Inc. (ALNA) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - January 12 at 5:27 PM
finance.yahoo.com logoAllena Pharmaceuticals to Present at Upcoming Investor Conferences in January
finance.yahoo.com - January 4 at 8:19 AM
finance.yahoo.com logoAllena Pharmaceuticals Increases Previously Announced Bought Deal to $13.0 Million
finance.yahoo.com - December 2 at 12:52 AM
seekingalpha.com logoAllena Pharmaceuticals announces $10M bought deal
seekingalpha.com - December 1 at 7:51 PM
finance.yahoo.com logoAllena Pharmaceuticals Announces $10.0 Million Bought Deal Offering
finance.yahoo.com - December 1 at 7:51 PM
finance.yahoo.com logoAllena Pharmaceuticals Announces Appointment of David J. Clark, M.D., M.R.C.P. as Chief Medical Officer
finance.yahoo.com - December 1 at 2:51 PM
seekingalpha.com logoAllena Pharma's ALLN-346 shows encouraging action in early-stage study
seekingalpha.com - November 30 at 3:45 PM
finance.yahoo.com logoAllena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346
finance.yahoo.com - November 30 at 9:39 AM
finance.yahoo.com logoAllena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 9 at 8:32 AM
Get Allena Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALNA and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.